Last reviewed · How we verify

moxifloxacin 0,5% + prednisolone 1%

Adapt Produtos Oftalmológicos Ltda. · Phase 3 active Small molecule

moxifloxacin 0,5% + prednisolone 1% is a fluoroquinolone antibiotic and corticosteroid Small molecule drug developed by Adapt Produtos Oftalmológicos Ltda.. It is currently in Phase 3 development for Bacterial conjunctivitis, keratitis, and blepharitis. Also known as: moxifloxacin 0,5%, prednisolone 1%.

Moxifloxacin is a fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV, while prednisolone is a corticosteroid that reduces inflammation by inhibiting phospholipase A2 and other pro-inflammatory enzymes.

Moxifloxacin is a fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV, while prednisolone is a corticosteroid that reduces inflammation by inhibiting phospholipase A2 and other pro-inflammatory enzymes. Used for Bacterial conjunctivitis, keratitis, and blepharitis.

At a glance

Generic namemoxifloxacin 0,5% + prednisolone 1%
Also known asmoxifloxacin 0,5%, prednisolone 1%
SponsorAdapt Produtos Oftalmológicos Ltda.
Drug classfluoroquinolone antibiotic and corticosteroid
TargetDNA gyrase and topoisomerase IV, phospholipase A2
ModalitySmall molecule
Therapeutic areaOphthalmology
PhasePhase 3

Mechanism of action

Moxifloxacin's mechanism of action involves binding to the bacterial DNA gyrase and topoisomerase IV enzymes, thereby inhibiting bacterial DNA replication and transcription. Prednisolone, on the other hand, works by inhibiting the production of pro-inflammatory enzymes, such as phospholipase A2, which are involved in the inflammatory response.

Approved indications

Common side effects

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about moxifloxacin 0,5% + prednisolone 1%

What is moxifloxacin 0,5% + prednisolone 1%?

moxifloxacin 0,5% + prednisolone 1% is a fluoroquinolone antibiotic and corticosteroid drug developed by Adapt Produtos Oftalmológicos Ltda., indicated for Bacterial conjunctivitis, keratitis, and blepharitis.

How does moxifloxacin 0,5% + prednisolone 1% work?

Moxifloxacin is a fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV, while prednisolone is a corticosteroid that reduces inflammation by inhibiting phospholipase A2 and other pro-inflammatory enzymes.

What is moxifloxacin 0,5% + prednisolone 1% used for?

moxifloxacin 0,5% + prednisolone 1% is indicated for Bacterial conjunctivitis, keratitis, and blepharitis.

Who makes moxifloxacin 0,5% + prednisolone 1%?

moxifloxacin 0,5% + prednisolone 1% is developed by Adapt Produtos Oftalmológicos Ltda. (see full Adapt Produtos Oftalmológicos Ltda. pipeline at /company/adapt-produtos-oftalmol-gicos-ltda).

Is moxifloxacin 0,5% + prednisolone 1% also known as anything else?

moxifloxacin 0,5% + prednisolone 1% is also known as moxifloxacin 0,5%, prednisolone 1%.

What drug class is moxifloxacin 0,5% + prednisolone 1% in?

moxifloxacin 0,5% + prednisolone 1% belongs to the fluoroquinolone antibiotic and corticosteroid class. See all fluoroquinolone antibiotic and corticosteroid drugs at /class/fluoroquinolone-antibiotic-and-corticosteroid.

What development phase is moxifloxacin 0,5% + prednisolone 1% in?

moxifloxacin 0,5% + prednisolone 1% is in Phase 3.

What are the side effects of moxifloxacin 0,5% + prednisolone 1%?

Common side effects of moxifloxacin 0,5% + prednisolone 1% include Increased intraocular pressure, Cataract, Glaucoma.

What does moxifloxacin 0,5% + prednisolone 1% target?

moxifloxacin 0,5% + prednisolone 1% targets DNA gyrase and topoisomerase IV, phospholipase A2 and is a fluoroquinolone antibiotic and corticosteroid.

Related